Skip Navigation LinksHome > November 2013 - Volume 29 - Issue 11 > Subcutaneous and Perineural Botulinum Toxin Type A For Neuro...
Clinical Journal of Pain:
doi: 10.1097/AJP.0b013e31827eafff
Review Articles

Subcutaneous and Perineural Botulinum Toxin Type A For Neuropathic Pain: A Descriptive Review

Fabregat, Gustavo MD*; De Andrés, José MD, PhD, FIPP; Villanueva-Pérez, Vicente L. MD*; Asensio-Samper, Juan M. MD*

Collapse Box


Objective: Botulinum toxin is a neurotoxin that has been widely used in chronic pain for the treatment of multiple conditions with a component of localized muscle spasm. Recent studies suggest that botulinum toxin is effective in the treatment of neuropathic pain syndromes such as postherpetic neuralgia or painful scars.

Methods: We searched the PubMed and OvidSP databases. We also included cross-referencing bibliographies from primary and review articles.

Discussion: In this descriptive review, we evaluate the usefulness, safety, and potential pathophysiological mechanism of botulinum toxin type A for treatment of painful disorders with neuropathic component such as postherpetic neuralgia, diabetic neuropathy, or trigeminal neuralgia.

Conclusions: On the basis of the analysis of the reports published in the literature, it would seem that fractioned peripheral subcutaneous and perineural injections of botulinum toxin type A may be useful for the treatment of various chronic pain conditions with neuropathic component.

© 2013 by Lippincott Williams & Wilkins

Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.